SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-24-114268
Filing Date
2024-04-25
Accepted
2024-04-25 17:07:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFM14A d752872ddefm14a.htm DEFM14A 1581760
2 GRAPHIC g752872dsp001.jpg GRAPHIC 135602
3 GRAPHIC g752872dsp002.jpg GRAPHIC 114414
4 GRAPHIC g752872g42r61.jpg GRAPHIC 595728
  Complete submission text file 0001193125-24-114268.txt   2739538
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39971 | Film No.: 24877380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)